6th Euro VT/VF-Meeting on the 5th/6th December 2014 in Berlin
■ Invitation 6th Euro VT/VF-Meeting on the 5th/6th December 2014 in Berlin
Dear colleagues, Dear friends, as the 5th Euro VT / VF meeting is now behind us and it once again surpassed all our previous meetings despite some impairments caused by the storm “Xaver”. Many important ideas and impulses from this conference will influence and…
Invitation as PDF for download.
Video: Professor Karl-Heinz Kuck, MD, Ph.D invites to the 6th EuroVT/VF-Meeting in Berlin.
At the 6th EURO VT/VF Meeting in Berlin on december 5th/6th, the world's leading specialists in the field of cardiac arrhythmia met once again to share their experiences and discuss new approaches to diagnosis and treatment.
One focus of the high-powered symposium this year was sports, ventricular arrhythmias and sudden cardiac death.
Press release as PDF for download.
Video: In this interview Professor Karl-Heinz Kuck, MD, Ph.D, the conferences scientific director, sums up the most interesting topics covered on the 6th EURO VT/VF meeting 2014 in Berlin. The most important ones were sports with arrhythmia, the role of rotors in the mechanisms of ventricular fibrillation, new imaging.
Video: Interview with Prof. Kalyanam Shivkumar (UC Los Angeles) on the role of the autonomic nervous system in the development of ventricular arrhythmia and promising future treatment strategies.
5th Euro VT/VF-Meeting on the 6th/7th December 2013 in Berlin
Video: In this interview Professor Karl-Heinz Kuck, MD, Ph.D, the conferences scientific director, sums up the most interesting topics covered in Berlin. The most important ones were leadless pacing, the danish registry of ICD implantations, the four most interesting trials in the field of arrhythmia and heart failure, the role oft the autonomous nervous system in patients with arrhythmias like atrial fibrillation and ventricular tachycardia and the discussion about sports and inherited arrhythmias. Another big topic were new strategies to avoid complications and infections in patients with implanted devices like pacemakers and ICDs.
Video: In this interview Professor Michael J. Ackerman, MD, Ph.D from the Mayo Clinic at Rochester MN, USA speaks about the Left Cardiac Sympathetic Denervation Therapy (LCSD) in patients with malignant VF syndromes. Though this technique itself is not very new but known for decades it is going to be a valuable further treatment option among pharmacologic therapies and ICD. The pediatric cardiologist successfully treated infants, small children and adults and gives an overview about how the procedure is performed, what complications could occur, which patients would profit from a LCSD and which ones would not. And he points out: LCSD is helpful, but it is not a cure. Ackerman presented this promising treatment option at the 5th Euro VT/VF 2013 meeting in Berlin, Germany.
Video: Professor Michael J. Ackerman, MD, Ph.D from the Mayo Clinic at Rochester MN, USA spoke at the 5th Euro VT/VF Meeting about athletes with arrhythmias like the Long QT Syndrome or the Brugada Syndrome taking part in competetive sports. The existing guidelines in the US and europe are not evidence based but just well-meant advice trying to prevent any risk for these athletes, Ackerman says. He called for a paradigm shift to provide the athletes with valuable data and information to decide for themselves whether they are willing to take the residual risk and continue their training and competitive activity.
The organizers of the 5th Euro VT/VF-Meeting 2013 in Berlin
Prof. Dr. Karl-Heinz Kuck, Asklepios Klinik St. Georg, Hamburg, Germany
Prof. Dr. Paolo Della Bella, Ospedale San Raffaele, Milano, Italy
Prof. Dr. Gerhard Hindricks, Universität Leipzig Herzzentrum, Leipzig, Germany
Prof. Dr. Pierre Jais, Université Victor Segalen Bordeaux II, Bordeaux, France
Press release (in German) as PDF for download.
Program as PDF for download.
■ Press articles (in German) for the VT/VF-Meeting
each as PDF for download